JPH07247474A - Gelling agent for organic solvent or oil and fat - Google Patents

Gelling agent for organic solvent or oil and fat

Info

Publication number
JPH07247474A
JPH07247474A JP6787594A JP6787594A JPH07247474A JP H07247474 A JPH07247474 A JP H07247474A JP 6787594 A JP6787594 A JP 6787594A JP 6787594 A JP6787594 A JP 6787594A JP H07247474 A JPH07247474 A JP H07247474A
Authority
JP
Japan
Prior art keywords
oil
gelling agent
sample
glu
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6787594A
Other languages
Japanese (ja)
Other versions
JP2921731B2 (en
Inventor
Hiroyoshi Shirai
汪芳 白井
Kenji Hanabusa
謙二 英
Minoru Nishida
穣 西田
Takashi Murata
崇 村田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oil Mills Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Priority to JP6787594A priority Critical patent/JP2921731B2/en
Publication of JPH07247474A publication Critical patent/JPH07247474A/en
Application granted granted Critical
Publication of JP2921731B2 publication Critical patent/JP2921731B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a gelling agent for organic solvent or oil and fat, containing a specific cyclic dipeptide as an active component, forming a uniform and smooth gel, having excellent feeling and gelling performance and useful as a waste-oil treating agent, etc. CONSTITUTION:This gelling agent for organic solvent or oil and fat contains glutamic acid or its alkyl ester, a compound selected from glycine, alanine, valine, leucine, isoleucine and phenylalanine and preferably 50-100wt.% of a cyclic dipeptide expressed by formula I [A is H, CH3, (CH3)2CH, (CH3)2CHCH2, (C2H5)(CH2)CH or group of formula II; R is H or a 1-22C alkyl] as active components. The gelling agent is preferably added to an organic solvent or oil and fat in an amount of 0.1-5W/V%.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、特定のアミノ酸からな
る環状ジペプチドを有効成分とする有機溶媒または油脂
類のゲル化剤に係わる。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a gelling agent for organic solvents or fats and oils containing a cyclic dipeptide consisting of a specific amino acid as an active ingredient.

【0002】[0002]

【従来の技術】従来、水性系のゲル化剤に比べて油性系
のゲル化剤に関する研究、報告は数多く見当たらなかっ
た。しかし近年、油性系ゲル化剤の中ではひまし油を原
料として得られる12−ヒドロキシステアリン酸が廃油
処理剤として上市され、この分野での開発は最近とみに
進んでいる。ただし12−ヒドロキシステアリン酸はゲ
ル化させる油性物質の種類が限られており、得られるゲ
ルの感触もボソついたものになりやすく、その応用範囲
が狭いことが難点であった。
2. Description of the Related Art Heretofore, many studies and reports concerning oil-based gelling agents have not been found as compared with aqueous gelling agents. However, in recent years, among oily gelling agents, 12-hydroxystearic acid obtained from castor oil as a raw material has been marketed as a waste oil treatment agent, and the development in this field has been progressing recently. However, 12-hydroxystearic acid has limited types of oily substances to be gelled, and the obtained gel tends to have a dull feel, and its application range is narrow.

【0003】一方、これらの問題点を解決するために各
種のアミノ酸を利用したゲル化剤(例えばN−ラウロイ
ル−L−グルタミン酸−α,γ−ジ−n−ブチルアミ
ド)が開発されている。これはアミノ酸そのものを化学
的に変性させることにより、あるいはアミノ基やカルボ
キシル基等の官能基に反応させる物質を選択することに
より、様々な有機溶剤ならびに油脂をゲル化せしめる化
合物を得ることができるものである。またそのゲル強度
に関しても、前記と同様の処理を施しアミノ酸誘導体を
調製することにより調節できることから、数多くの検討
がなされている。しかしながら、これらのアミノ酸系油
性ゲル化剤は、例えば特開昭51−91884号公報に
記載されているような直鎖状型ペプチド誘導体が中心で
あった。またこれらのペプチド誘導体では、ゲル化能力
および得られるゲルの感触等については必ずしも満足で
きるものではなかった。
On the other hand, in order to solve these problems, gelling agents utilizing various amino acids (for example, N-lauroyl-L-glutamic acid-α, γ-di-n-butylamide) have been developed. This is a compound that can gel various organic solvents and fats and oils by chemically modifying the amino acid itself or by selecting a substance that reacts with a functional group such as an amino group or a carboxyl group. Is. Also, the gel strength can be adjusted by preparing the amino acid derivative by carrying out the same treatment as described above, and therefore, many studies have been conducted. However, these amino acid-based oily gelling agents were mainly linear peptide derivatives as described in, for example, JP-A-51-91884. Further, these peptide derivatives were not always satisfactory in gelling ability and feel of the resulting gel.

【0004】[0004]

【発明が解決しようとする課題】本発明者らは、かかる
現状を踏まえ、各種アミノ酸系化合物を作成し、そのゲ
ル形成能等について詳細に比較検討した結果、本発明を
完成するに至ったものである。すなわち本発明は、従来
の油性系ゲル化剤に比べてゲル化能に優れ、感触の良好
なゲルを形成するゲル化剤を提供することを目的とす
る。
SUMMARY OF THE INVENTION The present inventors have completed the present invention as a result of preparing various amino acid compounds based on the present situation and comparing and examining the gel forming ability and the like in detail. Is. That is, it is an object of the present invention to provide a gelling agent which is excellent in gelling ability as compared with a conventional oily gelling agent and forms a gel having a good feel.

【0005】[0005]

【課題を解決するための手段】前記目的を達成するため
に、本発明は、グルタミン酸またはそのアルキルエステ
ルと、グリシン、アラニン、バリン、ロイシン、イソロ
イシンおよびフェニルアラニンからなる群より選ばれる
1種との下記一般式(1)で示される環状ジペプチドを
有効成分とする有機溶媒または油脂類のゲル化剤、をそ
の要旨とする。
In order to achieve the above object, the present invention provides a glutamic acid or an alkyl ester thereof and one of the following selected from the group consisting of glycine, alanine, valine, leucine, isoleucine and phenylalanine. The gist of the invention is a gelling agent for organic solvents or fats and oils containing the cyclic dipeptide represented by the general formula (1) as an active ingredient.

【化4】 〔ただし式(1)中、AはH、CH3 、(CH3 2
H、(CH3 2 CHCH2 、(C2 5 )(CH3
CHまたは
[Chemical 4] [However, in formula (1), A is H, CH 3 , (CH 3 ) 2 C
H, (CH 3) 2 CHCH 2, (C 2 H 5) (CH 3)
CH or

【化5】 であり、RはHまたは炭素数1〜22の直鎖状あるいは
側鎖状アルキル基である。〕
[Chemical 5] And R is H or a linear or side chain alkyl group having 1 to 22 carbon atoms. ]

【0006】本発明のゲル化剤において必須する成分
は、脂肪族酸性アミノ酸であるグルタミン酸と、脂肪族
または芳香族中性アミノ酸であるグリシン、アラニン、
バリン、ロイシン、イソロイシンおよびフェニルアラニ
ンからなる群より選ばれる1種とが2個のアミド結合に
よって六員環構造を形成した環状ジペプチドであって、
かつ前記グルタミン酸にもとづくカルボキシル基が遊離
のものか、もしくは炭素数1〜22の直鎖状あるいは側
鎖状アルキルエステルに変換されたものである。かかる
環状ジペプチドは前記一般式(1)で示される。
The essential components in the gelling agent of the present invention are glutamic acid, which is an aliphatic acidic amino acid, and glycine and alanine, which are neutral aliphatic amino acids.
1 type selected from the group consisting of valine, leucine, isoleucine and phenylalanine is a cyclic dipeptide in which a 6-membered ring structure is formed by two amide bonds,
The carboxyl group based on the glutamic acid is free or is converted to a linear or side chain alkyl ester having 1 to 22 carbon atoms. Such a cyclic dipeptide is represented by the above general formula (1).

【0007】本発明の環状ジペプチドの原料アミノ酸
は、天然物由来の蛋白質の酸、アルカリもしくは酵素に
よる加水分解物を抽出して得られるもの、微生物の発酵
や培養産生物から分離したもの、または化学合成法によ
って得られるもののいずれでもよい。また、その光学異
性体はD体、L体およびDL体(ラセミ体)の差を問わ
ず使用することができるが、工業用原料として市販され
ているL体またはDL体が安価に入手でき、至便であ
る。
The starting amino acid of the cyclic dipeptide of the present invention is obtained by extracting a hydrolyzate of a protein derived from a natural product with an acid, an alkali or an enzyme, a product isolated from a fermentation or culture product of a microorganism, or a chemical product. Any of those obtained by a synthetic method may be used. Further, the optical isomer can be used regardless of the difference between D-form, L-form and DL-form (racemic form), but the L-form or DL-form commercially available as an industrial raw material can be obtained at low cost, It is convenient.

【0008】本発明の環状ジペプチドは、前記アミノ酸
を適宜選択して公知の方法を用いて合成することができ
る。例えばまず、前記酸性アミノ酸であるグルタミン酸
と、メタノール、エタノール、n−プロパノール、イソ
プロパノール、n−ブタノール、イソブタノール等のい
ずれかの低級アルコールとを塩化水素、硫酸、パラトル
エンスルホン酸、亜鉛、スズ等を触媒として、もしくは
無触媒下に、減圧あるいは常圧で加熱させてエステル化
反応せしめ、グルタミン酸の低級アルコールジエステル
を作成する。
The cyclic dipeptide of the present invention can be synthesized by a known method by appropriately selecting the above amino acids. For example, first, glutamic acid, which is the acidic amino acid, and any lower alcohol such as methanol, ethanol, n-propanol, isopropanol, n-butanol, and isobutanol are mixed with hydrogen chloride, sulfuric acid, paratoluenesulfonic acid, zinc, tin, and the like. Is used as a catalyst or in the absence of a catalyst to heat at reduced pressure or normal pressure to cause an esterification reaction to prepare a lower alcohol diester of glutamic acid.

【0009】一方、前記中性アミノ酸は、官能基のひと
つであるα−アミノ基を保護したのち、上記グルタミン
酸の低級アルコールジエステルとの間でアミド化反応を
行い、環状ジペプチドを形成させた後、α−アミノ基の
保護基を脱離させる。このための保護基としてはベンジ
ルオキシカルボニル基(Z基)、t−ブトキシカルボニ
ル基(Boc基)、9−フルオレニルメトキシカルボニ
ル基(Fmoc基)、3−ニトロ−2−ピリジンスルフ
ェニル基(Npys基)など数多く存在するが、脱離が
容易なZ基を導入することが一般的である。Z基の導入
は塩化ベンジルオキシカルボニル(Z−Cl)を用いSc
hotten-Baumann反応により、水酸化ナトリウム水溶液と
同時に滴下させて反応させる。
On the other hand, the neutral amino acid, after protecting the α-amino group which is one of the functional groups, undergoes an amidation reaction with the lower alcohol diester of glutamic acid to form a cyclic dipeptide, The protecting group for the α-amino group is removed. As a protecting group for this purpose, a benzyloxycarbonyl group (Z group), a t-butoxycarbonyl group (Boc group), a 9-fluorenylmethoxycarbonyl group (Fmoc group), a 3-nitro-2-pyridinesulfenyl group ( Npys group) exists in large numbers, but it is common to introduce a Z group that is easily eliminated. Benzyloxycarbonyl chloride (Z-Cl) was used to introduce the Z group, and Sc
By the hotten-Baumann reaction, the reaction is carried out by dropping simultaneously with an aqueous solution of sodium hydroxide.

【0010】ついで、前記したグルタミン酸の低級アル
コールジエステルとZ基を導入した前記中性アミノ酸と
を、ジシクロヘキシルカルボジイミド(DCC)を用い
て40℃で約半日間アミド化反応せしめ、直鎖状ジペプ
チド誘導体を調製し、これを前記低級アルコールあるい
は炭素数5〜10程度の炭化水素を溶媒として、パラジ
ウム炭素、ニッケル、白金等の触媒の存在下、室温付近
で数時間、水素ガスを吹き込んで脱保護基化する。この
ような脱保護基の方法としては、他にもトリフルオロ酢
酸や無水フッ化水素による酸処理方法が一般的で、ある
が短鎖ペプチドからの脱離の場合は穏和な接触還元法が
よく用いられる。該反応物から前記触媒を除去した後、
メシチレン、ジオキサン、ジクロロメタン、テトラヒド
ロフラン等に溶解し、数時間、還流させることにより本
発明の環状ジペプチド(グルタミン酸の低級アルコール
エステルと中性アミノ酸との環状化物)を結晶として得
ることができる。
Then, the lower alcohol diester of glutamic acid and the neutral amino acid having the Z group introduced therein are subjected to an amidation reaction at 40 ° C. for about half a day using dicyclohexylcarbodiimide (DCC) to give a linear dipeptide derivative. It is prepared and deprotected by using a lower alcohol or a hydrocarbon having about 5 to 10 carbon atoms as a solvent in the presence of a catalyst such as palladium carbon, nickel or platinum for several hours at room temperature by blowing hydrogen gas. To do. As a method for such a deprotecting group, other methods such as acid treatment with trifluoroacetic acid or anhydrous hydrogen fluoride are generally used. However, in the case of elimination from a short-chain peptide, a mild catalytic reduction method is often used. Used. After removing the catalyst from the reaction,
The cyclic dipeptide of the present invention (a cyclized product of a lower alcohol ester of glutamic acid and a neutral amino acid) can be obtained as crystals by dissolving in mesitylene, dioxane, dichloromethane, tetrahydrofuran or the like and refluxing for several hours.

【0011】なお該環状ジペプチドは、メタノール、エ
タノール等の低級アルコール類を溶媒として用いて再結
晶すればさらに高純度化することができる。また前記酸
性触媒の存在下に加水分解し、あるいは水酸化ナトリウ
ムまたは水酸化カリウム等のアルカリを用いてエステル
結合をケン化した後に塩酸等で中和すれば、原料グルタ
ミン酸に由来するカルボキシル基が遊離状態の環状ジペ
プチド(グルタミン酸と中性アミノ酸との環状化物)を
調製することができる。
The cyclic dipeptide can be further purified by recrystallization using a lower alcohol such as methanol or ethanol as a solvent. Further, if the hydrolysis is carried out in the presence of the acidic catalyst, or the ester bond is saponified with an alkali such as sodium hydroxide or potassium hydroxide and then neutralized with hydrochloric acid or the like, the carboxyl group derived from the raw material glutamic acid is released. A cyclic dipeptide (a cyclized product of glutamic acid and a neutral amino acid) can be prepared.

【0012】さらにまた、前記二種類の環状ジペプチド
(グルタミン酸に由来するカルボキシル基が低級アルコ
ールエステル化されたものおよび遊離のものを用いて、
炭素数1〜22、より好ましくは炭素数1〜18、最も
好ましくは2〜10の直鎖状あるいは側鎖状アルキル基
を有するアルコール類とともに、グルタミン酸の低級ア
ルコールエステルと中性アミノ酸との環状ジペプチドの
場合にはナトリウムメチラート、リチウムエチラート等
の金属アルコラート、リパーゼ、硫酸、パラトルエンス
ルホン酸等を触媒としてエステル交換反応せしめ、もし
くはグルタミン酸と中性アミノ酸との環状ジペプチドの
場合には硫酸、パラトルエンスルホン酸、亜鉛、スズ、
酸化チタン等を触媒としてエステル化反応せしめ、いず
れの場合からも原料グルタミン酸に由来するカルボキシ
ル基が炭素数1〜22の直鎖状あるいは側鎖状アルコー
ルでエステル化された環状ジペプチド(グルタミン酸の
該アルコールエステルと中性アミノ酸との環状化物)を
合成することができる。
Furthermore, the above-mentioned two kinds of cyclic dipeptides (one in which the carboxyl group derived from glutamic acid is lower alcohol esterified and one in which it is free) are used,
A cyclic dipeptide of a lower alcohol ester of glutamic acid and a neutral amino acid together with an alcohol having a linear or side chain alkyl group having 1 to 22 carbon atoms, more preferably 1 to 18 carbon atoms, and most preferably 2 to 10 carbon atoms. In the case of, a transesterification reaction is carried out using a metal alcoholate such as sodium methylate or lithium ethylate, lipase, sulfuric acid, p-toluenesulfonic acid, etc. as a catalyst, or in the case of a cyclic dipeptide of glutamic acid and a neutral amino acid, sulfuric acid, para Toluene sulfonic acid, zinc, tin,
The esterification reaction is carried out using titanium oxide as a catalyst, and in any case, the carboxyl group derived from the starting glutamic acid is esterified with a linear or side chain alcohol having 1 to 22 carbon atoms (a cyclic dipeptide (the alcohol of glutamic acid. A cyclized product of an ester and a neutral amino acid) can be synthesized.

【0013】ここで、炭素数1〜22の直鎖状あるいは
側鎖状アルコール類としては、メタノール、エタノー
ル、n−プロパノール、イソプロパノール、n−ブタノ
ール、2−ブタノール、n−ペンタノール、n−ヘキサ
ノール、シクロヘキサノール、n−ヘプタノール、n−
オクタノール、2,4,4−トリメチルペンタノール、
2−エチルヘキサノール、n−ノナノール、n−デカノ
ール、3,7−ジメチルオクタノール、ラウリルアルコ
ール、トリデカノール、ネオトリデカノール、ミリスチ
ルアルコール、ペンタデカノール、2−メチルテトラデ
カノール、5−メチルテトラデカノール、パルミチルア
ルコール、2,2−ジメチルテトラデカノール、ヘプタ
デカノール、ステアリルアルコール、オレイルアルコー
ル、メチル側鎖イソステアリルアルコール、2−ヘプチ
ルウンデカノール、ヘベニルアルコール、2−オクチル
ドデカノール等を例示できる。炭素数が22を超えるア
ルコール類の場合の環状ジペプチドでは、有機溶媒また
は油脂類に混合すると結晶状態を呈するので好ましくな
い。
The linear or side chain alcohols having 1 to 22 carbon atoms are methanol, ethanol, n-propanol, isopropanol, n-butanol, 2-butanol, n-pentanol, n-hexanol. , Cyclohexanol, n-heptanol, n-
Octanol, 2,4,4-trimethylpentanol,
2-ethylhexanol, n-nonanol, n-decanol, 3,7-dimethyloctanol, lauryl alcohol, tridecanol, neotridecanol, myristyl alcohol, pentadecanol, 2-methyltetradecanol, 5-methyltetradecanol , Palmityl alcohol, 2,2-dimethyltetradecanol, heptadecanol, stearyl alcohol, oleyl alcohol, methyl side chain isostearyl alcohol, 2-heptylundecanol, hevenyl alcohol, 2-octyldodecanol, etc. it can. In the case of alcohols having 22 or more carbon atoms, cyclic dipeptides are not preferable because they are crystallized when mixed with organic solvents or fats and oils.

【0014】本発明では、前記した中性アミノ酸とアル
コール類との種々の組み合わせが有効であるが、とりわ
けハロゲン系およ芳香族系有機溶媒に対しては中性アミ
ノ酸が、好ましくはグリシン、アラニン、バリン、ロイ
シン、フェニルアラニン、より好ましくはグリシン、バ
リン、ロイシン、フェニルアラニンと炭素数1〜12の
アルコール類との組み合わせが望ましく、また油脂類に
対しては中性アミノ酸が、好ましくはグリシン、アラニ
ン、バリン、ロイシン、イソロイシン、フェニルアラニ
ン、より好ましくはグリシン、アラニン、バリン、ロイ
シン、フェニルアラニンと炭素数1〜18のアルコール
類との組み合わせが望ましい。
In the present invention, various combinations of the above-mentioned neutral amino acids and alcohols are effective, but especially for halogen-based and aromatic organic solvents, neutral amino acids are preferable, and glycine and alanine are preferable. , Valine, leucine, phenylalanine, more preferably a combination of glycine, valine, leucine, phenylalanine and alcohols having 1 to 12 carbon atoms, and neutral amino acids for oils and fats, preferably glycine, alanine, Valine, leucine, isoleucine, phenylalanine, and more preferably a combination of glycine, alanine, valine, leucine, phenylalanine and an alcohol having 1 to 18 carbon atoms is desirable.

【0015】かくして得られる各種環状ジペプチドは、
この1種または2種以上を適宜に使用して本発明のゲル
化剤とすることができる。さらに本発明のゲル化剤に
は、前記環状ジペプチドのほかに公知のゲル化剤、増粘
剤、ワックス類等を含有せしめてもよい。公知のゲル化
剤としては、ペクチン、アルギン酸ソーダ、カラギーナ
ン、ポリアクリル酸もしくはポリメタクリル酸ナトリウ
ム等の水性系ゲル化剤があり、またモクロウ、12−ヒ
ドロキシステアリン酸、N−ラウロイル−L−グルタミ
ン酸−α,γ−ジ−n−ブチルアミド等のN−アシル−
アミノ酸−アルキルアミド、新油性ショ糖脂肪酸エステ
ル、デキストリン脂肪酸エステル、デンプン脂肪酸エス
テル、ジベンジリデンソルビトール、ジベンジリデンキ
シリトール、アクリル酸もしくはメタクリル酸系ポリマ
ー等の油性系ゲル化剤がある。
The various cyclic dipeptides thus obtained are
The gelling agent of the present invention can be prepared by appropriately using one kind or two or more kinds. Further, the gelling agent of the present invention may contain known gelling agents, thickeners, waxes and the like in addition to the cyclic dipeptide. Known gelling agents include aqueous gelling agents such as pectin, sodium alginate, carrageenan, sodium polyacrylic acid or sodium polymethacrylate, and also mokuro, 12-hydroxystearic acid, N-lauroyl-L-glutamic acid- N-acyl-, such as α, γ-di-n-butylamide
There are oil-based gelling agents such as amino acid-alkylamides, new oily sucrose fatty acid esters, dextrin fatty acid esters, starch fatty acid esters, dibenzylidene sorbitol, dibenzylidene xylitol, acrylic acid or methacrylic acid based polymers.

【0016】公知の増粘剤としてアラビアガム、キサン
タンガム、グアーガム、トラガントガム、ローカストビ
ーンガム、カードラン、ジェランガム、亜麻種子粘質
物、カルボキシメチルセルロース、ヒドロキシエチルセ
ルロース、ヒドロキシプロピルメチルセルロース等を例
示できる。また公知のワックス類としては、カルナウバ
ワックス、キャンデリラワックス、シェラックロウ、ミ
ツロウ、シュガーケンワックス、ライスワックス、綿実
ワックス、ヒマワリワックス、パラフィンワックス、モ
ンタンワックス、ベイベリーワックス等を具体例として
あげることができる。
Examples of known thickeners include gum arabic, xanthan gum, guar gum, tragacanth gum, locust bean gum, curdlan, gellan gum, flax seed mucilage, carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose and the like. Examples of known waxes include carnauba wax, candelilla wax, shellac wax, beeswax, sugar wax, rice wax, cottonseed wax, sunflower wax, paraffin wax, montan wax, bayberry wax and the like. be able to.

【0017】本発明のゲル化剤は、前記環状ジペプチド
を20〜100重量%、好ましくは50〜100重量%
配合してなるものである。20重量%未満では、従来の
油性系ゲル化剤に比べて効果的なゲル化能を示すことが
できず、あるいは感触の良好なゲルを得にくくなる。本
発明のゲル化剤は、有機溶媒または油脂類に対し、0.
1〜10重量/容量%(有機溶媒または油脂類の単位容
量:mlに対する本発明のゲル化剤の添加重量:gの百
分率を示す。以下同じ。)、好ましくは0.1〜5重量
/容量%添加して良好なゲル化能を有する。0.1重量
/容量%未満では所望のゲルが得られず、10重量/容
量%を超過すると結晶化傾向が大きくなる。
The gelling agent of the present invention contains the cyclic dipeptide in an amount of 20 to 100% by weight, preferably 50 to 100% by weight.
It is a mixture. When it is less than 20% by weight, it is not possible to exhibit an effective gelling ability as compared with the conventional oil-based gelling agent, or it is difficult to obtain a gel having a good feel. The gelling agent of the present invention can be applied to organic solvents or fats and oils in an amount of 0.
1 to 10% by weight / volume (percentage of addition amount of gelling agent of the present invention: g per unit volume of organic solvent or oil / fat: ml, the same applies hereinafter), preferably 0.1 to 5% by weight / volume % To have a good gelling ability. If it is less than 0.1% by weight / volume, the desired gel cannot be obtained.

【0018】本発明においては種々の有機溶媒を対象に
できるが、とりわけハロゲン系溶媒および芳香族系溶媒
とくにベンゼン系溶媒が好ましく、この具体例として四
塩化炭素、ベンゼン、トルエン、キシレン、メトキシベ
ンゼン、クロルベンゼン、ニトロベンゼン等がある。ま
た油脂類としては、常温にて好ましくは液状ないし半固
体状、より好ましくは液状を呈するものであって、大豆
油、菜種油、コーン油、サフラワー油、ヒマワリ油、綿
実油、オリーブ油、パーム油、アマニ油、ヒマシ油、魚
油、豚脂、牛脂、およびこれらを混合、分別あるいはエ
ステル交換した加工油脂等を例示でき、さらにトリアセ
チン、トリブチリン、トリカプリリン、カプリル酸およ
びカプリン酸の混合脂肪酸からなるトリグリセリド等の
炭素数2〜10程度の単一もしくは混合脂肪酸を構成脂
肪酸とするグリセリド類(ジグリセリド、モノグリセリ
ドを含んでいてもよい)を対象とすることができる。
In the present invention, various organic solvents can be used, but halogen-based solvents and aromatic solvents, especially benzene-based solvents are preferable, and specific examples thereof include carbon tetrachloride, benzene, toluene, xylene and methoxybenzene. There are chlorobenzene and nitrobenzene. The oils and fats are preferably liquid or semi-solid at room temperature, more preferably those that are liquid, soybean oil, rapeseed oil, corn oil, safflower oil, sunflower oil, cottonseed oil, olive oil, palm oil, Examples include linseed oil, castor oil, fish oil, lard, beef tallow, and processed fats and oils obtained by mixing, fractionating, or transesterifying these, and triglycerides composed of mixed fatty acids of triacetin, tributyrin, tricaprylin, caprylic acid, and capric acid. The glycerides (which may include diglycerides and monoglycerides) having a single or mixed fatty acid having 2 to 10 carbon atoms as a constituent fatty acid can be targeted.

【0019】本発明のゲル化剤を前記有機溶媒または油
脂類に所定量添加し、要すれば約40〜80℃に加熱
し、攪拌して混合、溶解せしめた後、常温付近(20〜
25℃)に静置すれば、ゲル化物を調製することができ
る。得られるゲル状物は、寒天やゼラチンのようなボソ
つきのあるものではなく、均一で滑らかな状態のもので
あり、常温で長期間保存しても液状部の発生がなく、該
混合系全体も流動化することはない。
A predetermined amount of the gelling agent of the present invention is added to the organic solvent or fats and oils, and if necessary, heated to about 40 to 80 ° C., stirred and mixed to dissolve, and then around room temperature (20 to 20 ° C.).
A gelled product can be prepared by allowing it to stand at 25 ° C. The gel-like product obtained is in a uniform and smooth state, unlike agar or gelatin, and has no liquid part even when stored at room temperature for a long time. It does not become liquid.

【0020】[0020]

【実施例】以下の合成例、実施例および比較例におい
て、%はとくにことわらない限り重量基準である。 合成例1 L−グルタミン酸73.5gを無水エタノール1リット
ルに懸濁し、乾燥塩化水素ガスを導入した。時々振り混
ぜ、L−グルタミン酸を溶解させ、氷水で冷却しさらに
塩化水素を飽和するまで導入した。該混合物を湿気が入
らないようにして、室温で4時間放置し、再び0〜5℃
に冷却し、終夜放置した。得られた塩酸塩を濾取し、冷
エタノールと無水エーテルで順次洗浄した後、水酸化ナ
トリウムを入れたデシケータ中で減圧乾燥し、これをさ
らにエタノールとエーテルで再結晶して、L−グルタミ
ン酸ジエチル〔以下、L−Glu(O−Et)2 と略
す〕86.5gを得た。
EXAMPLES In the following synthesis examples, examples and comparative examples,% is by weight unless otherwise specified. Synthesis Example 1 73.5 g of L-glutamic acid was suspended in 1 liter of absolute ethanol, and dry hydrogen chloride gas was introduced. The mixture was occasionally shaken to dissolve L-glutamic acid, cooled with ice water, and further introduced with hydrogen chloride until saturated. Keep the mixture dry for 4 hours at room temperature and again at 0-5 ° C.
It was cooled to and left overnight. The obtained hydrochloride salt was collected by filtration, washed successively with cold ethanol and anhydrous ether, dried under reduced pressure in a desiccator containing sodium hydroxide, and recrystallized from ethanol and ether to give diethyl L-glutamate. [Hereinafter, abbreviated as L-Glu (O-Et) 2 ] 86.5 g was obtained.

【0021】一方、L−ロイシン65.6gを2N水酸
化ナトリウム水溶液250mlに溶かし、エーテル50ml
を溶媒として加え、氷温下で10分間攪拌した後、これ
に塩化ベンジルオキシカルボニル85.3gと2N水酸
化ナトリウム水溶液250mlとを同時に10回に分けて
添加した。この溶液を分液ロートに移し、エーテルで洗
いながら水層部を分取した。これに酢酸エチルを250
ml程度加え、1N塩酸600mlを加えて攪拌した。水洗
を3回繰り返し、酢酸エチル層に硫酸マグネシウムを加
え、水分を除去しこれを濾紙で濾別した後、濾液をナス
フラスコに入れ、約50℃で酢酸エチルを減圧留去し
た。これに新たな酢酸エチル150ml程度を温めながら
加え、さらに石油エーテルを少量ずつ加えながら振とう
した。液が濁る状態になるまで石油エーテルを加え、こ
れを冷蔵庫にて放置して再結晶を行い、Z化ロイシン
(以下、Z−L−Leuと略す)75.0gを得た。
On the other hand, 65.6 g of L-leucine was dissolved in 250 ml of 2N aqueous sodium hydroxide solution, and 50 ml of ether was added.
Was added as a solvent, and the mixture was stirred at ice temperature for 10 minutes, and then 85.3 g of benzyloxycarbonyl chloride and 250 ml of a 2N sodium hydroxide aqueous solution were simultaneously added in 10 batches. The solution was transferred to a separating funnel and the aqueous layer was separated while washing with ether. Add 250 ml of ethyl acetate to this
About 1 ml of hydrochloric acid was added, and the mixture was stirred. The washing with water was repeated 3 times, magnesium sulfate was added to the ethyl acetate layer to remove water, and this was filtered off with a filter paper. Then, the filtrate was put into an eggplant-shaped flask, and ethyl acetate was distilled off under reduced pressure at about 50 ° C. About 150 ml of new ethyl acetate was added to this while warming, and petroleum ether was added little by little and shaken. Petroleum ether was added until the liquid became cloudy, and this was left in a refrigerator for recrystallization to obtain 75.0 g of Z-leucine (hereinafter abbreviated as Z-L-Leu).

【0022】次にL−Glu(O−Et)2 とZ−L−
Leuとの反応を行った。ナスフラスコにZ−L−Le
u26.5gと酢酸エチル400mlを加え、氷浴中で攪
拌した。これにジシクロヘキシルカルボジイミド(DC
C)22.7gを加えて室温で1時間攪拌することによ
り系は白濁した。この状態でL−Glu(O−Et) 2
17.5gを加えて1時間攪拌し、さらに40℃まで加
温した後に一晩攪拌を続けた。この溶液に酢酸エチル8
00mlを加え、加熱攪拌した後、生じた沈殿部を除去
し、酢酸エチルを減圧留去することにより再度結晶化さ
せた。冷却後、これを濾過して結晶を得、濾液は酢酸エ
チル800mlに溶かした後、同様の処理をして結晶を
得、両結晶を併せた。これを真空乾燥することにより、
L−Glu(O−Et)2 とZ−L−Leuとの直鎖状
ジペプチド誘導体〔以下、Z−L−Leu−L−Glu
(O−Et)2 と略す〕20.8gを得た。
Next, L-Glu (O-Et)2And Z-L-
Reaction with Leu was performed. Z-L-Le in an eggplant flask
Add 26.5 g of u and 400 ml of ethyl acetate and stir in an ice bath.
I stirred. Dicyclohexylcarbodiimide (DC
C) By adding 22.7 g and stirring at room temperature for 1 hour,
The system became cloudy. In this state, L-Glu (O-Et) 2
Add 17.5g and stir for 1 hour.
After warming, stirring was continued overnight. Ethyl acetate 8 in this solution
After adding 00 ml and heating and stirring, the generated precipitate was removed.
It was recrystallized by distilling off ethyl acetate under reduced pressure.
Let After cooling, this was filtered to obtain crystals, and the filtrate was ethyl acetate.
After dissolving in 800 ml of chill, the same treatment is performed to form crystals.
Then, both crystals were combined. By vacuum drying this,
L-Glu (O-Et)2And Z-L-Leu straight chain
Dipeptide derivative [hereinafter referred to as ZL-Leu-L-Glu
(O-Et)220.8 g was obtained.

【0023】Z−L−Leu−L−Glu(O−Et)
2 20gをメタノール500mlに溶解し、触媒として1
0%パラジウム担持カーボン2%を加え、室温で6時
間、水素ガスを注入して脱Z基化した。前記触媒を濾別
し、濾液を濃縮した後、得られたL−Leu−L−Gl
u(O−Et)2 をメシチレン(2,4,6−トリメチ
ルベンゼン)400mlに溶かし、5時間還流して環状化
反応を行わせた。該反応後、メシチレンを100mlまで
濃縮し、析出した結晶を濾紙で濾別し、石油エーテルで
洗浄、減圧乾燥して粗生成物を得、これをさらにエタノ
ール100mlで再結晶し、L−グルタミン酸モノエチル
エステルとL−ロイシンとが2個のアミド結合を介して
六員環構造となった環状ジペプチド〔以下、cyclo
(L−Leu−L−Glu(O−Et))と略す〕(試
料No.1)11.6gを得た。
ZL-Leu-L-Glu (O-Et)
2 20 g was dissolved in 500 ml of methanol and used as a catalyst 1
2% of 0% palladium-supported carbon was added, and hydrogen gas was injected at room temperature for 6 hours to deZ-group. After the catalyst was filtered off and the filtrate was concentrated, the obtained L-Leu-L-Gl was obtained.
u (O-Et) 2 was dissolved in 400 ml of mesitylene (2,4,6-trimethylbenzene) and refluxed for 5 hours to carry out a cyclization reaction. After the reaction, mesitylene was concentrated to 100 ml, and the precipitated crystals were separated by filtration with filter paper, washed with petroleum ether and dried under reduced pressure to obtain a crude product, which was recrystallized with 100 ml of ethanol to give L-glutamic acid monohydrate. A cyclic dipeptide in which ethyl ester and L-leucine have a six-membered ring structure through two amide bonds [hereinafter, referred to as cyclo
Abbreviated as (L-Leu-L-Glu (O-Et))] (Sample No. 1), 11.6 g was obtained.

【0024】前記反応工程の概要を反応式で示すと式
(2)および式(3)で表される。
The outline of the reaction step is represented by the reaction formulas, which are represented by the formulas (2) and (3).

【化6】 [Chemical 6]

【化7】 [Chemical 7]

【0025】合成例2、3 合成例1に記載の方法で得たL−Glu(O−Et)2
17.5gと、合成例1に記載の方法に準じて得たZ−
L−Val25.1gとを用い、同様の方法で処理して
L−グルタミン酸モノエチルエステルとL−バリンとの
環状ジペプチド〔以下、cyclo(L−Val−L−
Glu(O−Et))と略す〕(試料No.2)25.6
gを得た。さらに合成例1と同様の方法によりL−グル
タミン酸モノエチルエステルとL−グリシンとの環状ジ
ペプチド〔以下、cyclo(L−Gly−L−Glu
(O−Et))と略す〕(試料No.3)を得た。
Synthesis Examples 2 and 3 L-Glu (O-Et) 2 obtained by the method described in Synthesis Example 1
17.5 g and Z-obtained according to the method described in Synthesis Example 1.
L-Val 25.1 g was used and treated in a similar manner to give a cyclic dipeptide of L-glutamic acid monoethyl ester and L-valine [hereinafter referred to as cyclo (L-Val-L-
Glu (O-Et))] (Sample No. 2) 25.6
g was obtained. Furthermore, a cyclic dipeptide of L-glutamic acid monoethyl ester and L-glycine [hereinafter referred to as cyclo (L-Gly-L-Glu was prepared by the same method as in Synthesis Example 1.
(O-Et))] (Sample No. 3) was obtained.

【0026】合成例4 合成例1で得たcyclo(L−Leu−L−Glu
(O−Et)(試料No.1)10gに1N−塩酸を含む
メタノール50mlを加えて1時間還流してエチルエステ
ルの加水分解反応を行わせた。該反応後、メタノールを
減圧で留去し、石油エーテル50mlで洗浄後、減圧乾燥
して粗生成物を得、これをさらにエタノール20mlで再
結晶してL−グルタミン酸とL−ロイシンとが2個のア
ミド結合を介して六員環構造となった環状ジペプチド
〔以下、cyclo(L−Leu−L−Glu(O
H))と略す〕(試料No. 4)6.4gを得た。
Synthesis Example 4 The cyclo (L-Leu-L-Glu obtained in Synthesis Example 1 was used.
To 10 g of (O-Et) (Sample No. 1) was added 50 ml of methanol containing 1N-hydrochloric acid, and the mixture was refluxed for 1 hour to cause the hydrolysis reaction of ethyl ester. After the reaction, methanol was distilled off under reduced pressure, washed with 50 ml of petroleum ether, and dried under reduced pressure to obtain a crude product, which was recrystallized with 20 ml of ethanol to obtain two L-glutamic acid and L-leucine. A cyclic dipeptide having a six-membered ring structure through an amide bond of [(hereinafter, cyclo (L-Leu-L-Glu (O
H))] (Sample No. 4) (6.4 g) was obtained.

【0027】合成例5〜10 合成例1で得たcyclo(L−Leu−L−Glu
(O−Et))(試料No.1)10gにラウリルアルコ
ール8.3gを加え、パラトルエンスルホン酸30mgを
触媒として100mmHgの減圧下で4時間、120℃に加
熱して攪拌した。その後、2重量倍のクロロホルムに溶
解し、シリカゲルクロマトグラフィーに供した。これに
より未反応のアルコール類画分を除き、エステル交換
(アルコリシス)反応物を含む画分を得た。さらにクロ
ロホルムを減圧留去してL−グルタミン酸モノラウリル
エステルとL−ロイシンとの環状ジペプチド〔以下、c
yclo(L−Leu−L−Glu(O−La))と略
す〕(試料No.5)を2.8g得た。同様の方法で、試
料No.1と3,7−ジメチルオクタノールとからL−
グルタミン酸モノ3,7−ジメチルオクチルエステルと
L−ロイシンとの環状ジペプチド〔以下、cyclo
(L−Leu−L−Glu(O−Mo))と略す〕(試
料No. 6)を得た。
Synthesis Examples 5 to 10 The cyclo (L-Leu-L-Glu obtained in Synthesis Example 1 was used.
8.3 g of lauryl alcohol was added to 10 g of (O-Et)) (sample No. 1), and 30 mg of p-toluenesulfonic acid was used as a catalyst and heated at 120 ° C. for 4 hours under reduced pressure of 100 mmHg and stirred. Then, it melt | dissolved in chloroform 2 times weight and it used for the silica gel chromatography. As a result, the unreacted alcohol fraction was removed to obtain a fraction containing a transesterification (alcoholsis) reaction product. Further, chloroform was distilled off under reduced pressure to remove a cyclic dipeptide of L-glutamic acid monolauryl ester and L-leucine [hereinafter, c
abbreviated as yclo (L-Leu-L-Glu (O-La))] (Sample No. 5) was obtained. In the same manner, the sample No. L- from 1 and 3,7-dimethyloctanol
Cyclic dipeptide of glutamic acid mono 3,7-dimethyloctyl ester and L-leucine [hereinafter referred to as cyclo
(Abbreviated as L-Leu-L-Glu (O-Mo))] (Sample No. 6) was obtained.

【0028】さらに合成例2で得たcyclo(L−V
al−L−Glu(O−Et))(試料No.2)に対
し、ラウリルアルコール、ステアリルアルコール、3,
7−ジメチルオクタノールおよび2−エチルヘキサノー
ルのいずれかひとつを用い、同様の方法により、それぞ
れL−グルタミン酸モノラウリルエステルとL−バリン
との環状ジペプチド〔以下、cyclo(L−Val−
L−Glu(O−La))と略す〕(試料No.7)、L
−グルタミン酸モノステアリルエステルとL−バリンと
の環状ジペプチド〔以下、cyclo(L−Val−L
−Glu(O−St))と略す〕(試料No.8)、L−
グルタミン酸モノ3,7−ジメチルオクチルエステルと
L−バリンとの環状ジペプチド〔以下、cyclo(L
−Val−L−Glu(O−Mo))と略す〕(試料N
o.9)、L−グルタミン酸モノ2−エチルヘキシルエ
ステルとL−バリンとの環状ジペプチド〔以下、cyc
lo(L−Val−L−Glu(O−Eh))と略す〕
(試料No.10)を得た。
Further, the cyclo (LV) obtained in Synthesis Example 2 was used.
al-L-Glu (O-Et)) (Sample No. 2), lauryl alcohol, stearyl alcohol, 3,
A cyclic dipeptide of L-glutamic acid monolauryl ester and L-valine [hereinafter, referred to as cyclo (L-Val-
L-Glu (O-La))] (Sample No. 7), L
-A cyclic dipeptide of glutamic acid monostearyl ester and L-valine [hereinafter referred to as cyclo (L-Val-L
-Glu (O-St))] (Sample No. 8), L-
Cyclic dipeptide of glutamic acid mono 3,7-dimethyloctyl ester and L-valine [hereinafter referred to as cyclo (L
-Val-L-Glu (O-Mo))] (Sample N
o. 9), a cyclic dipeptide of L-glutamic acid mono-2-ethylhexyl ester and L-valine [hereinafter referred to as cyc
abbreviated as lo (L-Val-L-Glu (O-Eh))]
(Sample No. 10) was obtained.

【0029】実施例1 cyclo(L−Leu−L−Glu(O−Et))
(試料No.1)の、各種有機溶媒または油脂類に対する
ゲル化能を調べた。すなわち、蓋付き試験管に前記環状
ジペプチドを300mg、有機溶媒または油脂類を10ml
採り、加熱、溶解した後、25℃に冷却したときの状態
を観察した。内容物全体がゲル状を呈し、試験管を傾け
たときに液状物が滲出せず、かつ流動化しないものをゲ
ルとし、ゲルになったものについてはさらにその臨界ゲ
ル化濃度(有機溶媒または油脂類1mlをゲル化させるた
めに必要な環状ジペプチドの最少重量:gの百分率、単
位は重量/容量%、以下CGCという。)を求めた。
Example 1 cyclo (L-Leu-L-Glu (O-Et))
The gelation ability of (Sample No. 1) with respect to various organic solvents or fats and oils was examined. That is, in a test tube with a lid, 300 mg of the cyclic dipeptide, 10 ml of an organic solvent or oils and fats
After collecting, heating and melting, the state when cooled to 25 ° C. was observed. A gel is used when the entire contents are in the form of gel, and the liquid does not exude when the test tube is tilted and does not fluidize.For gelled substances, the critical gelling concentration (organic solvent or oil or fat) The minimum weight of cyclic dipeptide required for gelling 1 ml of the class: percentage of g, unit: weight / volume%, hereinafter referred to as CGC) was determined.

【0030】その結果、試料No.1のCGCは四塩化炭
素に対して2.0重量/容量%、ベンゼンに対して0.
6重量/容量%、トルエンに対して0.2重量/容量
%、メトキシベンゼンに対して0.7重量/容量%、ク
ロルベンゼンに対して1.0重量/容量%、トリカプリ
リンに対して1.0重量/容量%、トリオレインに対し
て0.9重量/容量%、および大豆油に対して0.5重
量/容量%であり、試料No. 1の環状ジペプチドは有機
溶媒および油脂類に対してゲル化能を有し、本発明のゲ
ル化剤として適することが認められた。また、得られた
ゲルはいずれも均一で滑らかな感触であった。
As a result, the sample No. CGC of 1 is 2.0% by weight / volume% for carbon tetrachloride and 0.1% for benzene.
6 wt / vol%, 0.2 wt / vol% for toluene, 0.7 wt / vol% for methoxybenzene, 1.0 wt / vol% for chlorobenzene, 1 for tricaprylin 0.0 wt / vol%, 0.9 wt / vol% with respect to triolein, and 0.5 wt / vol% with soybean oil, the cyclic dipeptide of sample No. 1 was found in organic solvents and oils and fats. On the other hand, it was confirmed that it has gelling ability and is suitable as the gelling agent of the present invention. All the gels obtained had a uniform and smooth feel.

【0031】実施例2 cyclo(L−Val−L−Glu(O−Et))
(試料No.2)の、各種有機溶媒または油脂類に対する
ゲル化能を、実施例1と同様の方法により調べた。その
結果、試料No.2のCGCはトルエン、クロルベンゼ
ン、トリカプリリン、トリオレインおよび大豆油に対し
てそれぞれ0.2、1.1、2.1、2.3および0.
5各重量/容量%であり、試料No.2の環状ジペプチド
は有機溶媒および油脂類に対してゲル化能を有し、本発
明のゲル化剤として適していることが明らかになった。
また、得られたゲルはいずれも均一で滑らかな感触であ
った。
Example 2 cyclo (L-Val-L-Glu (O-Et))
The gelation ability of (Sample No. 2) with respect to various organic solvents or fats and oils was examined by the same method as in Example 1. As a result, the sample No. CGC of 2 was 0.2, 1.1, 2.1, 2.3 and 0.3 for toluene, chlorobenzene, tricaprylin, triolein and soybean oil, respectively.
5 is each weight / volume%, and sample No. It was revealed that the cyclic dipeptide of No. 2 has gelling ability with respect to organic solvents and oils and fats and is suitable as the gelling agent of the present invention.
All the gels obtained had a uniform and smooth feel.

【0032】実施例3 cyclo(L−Gly−L−Glu(O−Et))
(試料No. 3)の、各種有機溶媒または油脂類に対する
ゲル化能を、実施例1と同様の方法により調べた。その
結果、試料No.3のCGCはクロロホルム、ベンゼン、
トルエン、メトキシベンゼン、クロルベンゼン、ニトロ
ベンゼン、トリカプリリン、トリオレインおよび大豆油
に対してそれぞれ2.0、2.0、2.0、1.0、
1.0、1.0、0.4、0.3および0.3各重量/
容量%であり、試料No.3の環状ジペプチドは有機溶媒
および油脂類に対してゲル化能をもち、本発明のゲル化
剤として適することが認められた。また、得られたゲル
はいずれも均一で滑らかな感触であった。
Example 3 cyclo (L-Gly-L-Glu (O-Et))
The gelling ability of (Sample No. 3) with respect to various organic solvents or fats and oils was examined by the same method as in Example 1. As a result, the sample No. CGC of 3 is chloroform, benzene,
2.0, 2.0, 2.0, 1.0 for toluene, methoxybenzene, chlorobenzene, nitrobenzene, tricaprylin, triolein and soybean oil, respectively.
1.0, 1.0, 0.4, 0.3 and 0.3 each weight /
Volume%, sample No. It was confirmed that the cyclic dipeptide of 3 has a gelling ability with respect to organic solvents and oils and fats and is suitable as the gelling agent of the present invention. All the gels obtained had a uniform and smooth feel.

【0033】実施例4 cyclo(L−Leu−L−Glu(OH))(試料
No. 4)の、各種有機溶媒または油脂類に対するゲル化
能を、実施例1と同様の方法により調べた。その結果、
試料No. 4のCGCは大豆油に対して0.6重量/容量
%であり、試料No. 4の環状ジペプチドは油脂に対して
ゲル化能を有し、本発明のゲル化剤として適することが
わかった。また、得られたゲルは均一で滑らかな感触で
あった。
Example 4 cyclo (L-Leu-L-Glu (OH)) (Sample
The gelling ability of No. 4) against various organic solvents or oils and fats was examined by the same method as in Example 1. as a result,
The CGC of sample No. 4 was 0.6% by weight / volume with respect to soybean oil, and the cyclic dipeptide of sample No. 4 had gelation ability with respect to fats and oils and was suitable as the gelling agent of the present invention. I understood. The obtained gel had a uniform and smooth feel.

【0034】実施例5〜10 合成例5〜10で得たcyclo(L−Leu−L−G
lu(O−La))(試料No.5)、cyclo(L−
Leu−L−Glu(O−Mo))(試料No.6)、c
yclo(L−Val−L−Glu(O−La))(試
料No.7)、cyclo(L−Val−L−Glu(O
−St))(試料No.8)、cyclo(L−Val−
L−Glu(O−Mo))(試料No.9)およびcyc
lo(L−Val−L−Glu(O−Eh))(試料N
o.10)の、各種有機溶媒または油脂類に対するゲル
化能を、実施例1と同様の方法により調べた。その結
果、試料No.5のCGCは四塩化炭素、ベンゼン、トル
エンおよび大豆油に対して各々2.0、1.8、1.6
および0.8各重量/容量%であり、試料No.6のCG
Cは四塩化炭素、ベンゼンおよびトルエンに対して各
2.0重量/容量%であった。
Examples 5-10 Cyclo (L-Leu-L-G) obtained in Synthesis Examples 5-10
lu (O-La)) (Sample No. 5), cyclo (L-
Leu-L-Glu (O-Mo)) (Sample No. 6), c
yclo (L-Val-L-Glu (O-La)) (Sample No. 7), cyclo (L-Val-L-Glu (O
-St)) (Sample No. 8), cyclo (L-Val-
L-Glu (O-Mo)) (Sample No. 9) and cyc
lo (L-Val-L-Glu (O-Eh)) (Sample N
o. The gelling ability of 10) against various organic solvents or oils and fats was examined by the same method as in Example 1. As a result, the sample No. CGC of 5 was 2.0, 1.8 and 1.6 for carbon tetrachloride, benzene, toluene and soybean oil, respectively.
And 0.8% by weight / volume%, respectively. 6 CG
C was 2.0% by weight / volume% with respect to carbon tetrachloride, benzene and toluene, respectively.

【0035】また試料No.7のCGCは四塩化炭素に対
して1.3重量/容量%であり、試料No.8のCGCは
トリカプリリンおよび大豆油に対して0.8および0.
5重量/容量%であり、試料No.9のCGCは四塩化炭
素、トルエン、トリオレインおよび大豆油に対してそれ
ぞれ0.6、2.5、1.9および1.4各重量/容量
%であり、試料No.10のCGCは四塩化炭素、ベンゼ
ン、トルエン、クロルベンゼン、トリカプリリン、トリ
オレインおよび大豆油に対して各々2.0、0.9、
0.9、1.5、1.4、2.0および2.0各重量/
容量%であった。これらのことから、試料No.5〜No.
10の環状ジペプチドは有機溶媒または/および油脂類
に対してゲル化能を有し、本発明のゲル化剤として適す
ることがわかった。また得られたゲルはいずれも均一で
滑らかな感触であった。
Sample No. The CGC of No. 7 was 1.3% by weight / volume% with respect to carbon tetrachloride. CGC of 8 was 0.8 and 0.8 for tricaprylin and soybean oil.
5% by weight / volume%, and sample No. CGC of 9 was 0.6, 2.5, 1.9 and 1.4% by weight / volume for carbon tetrachloride, toluene, triolein and soybean oil, respectively. CGC of 10 is 2.0, 0.9, respectively for carbon tetrachloride, benzene, toluene, chlorobenzene, tricaprylin, triolein and soybean oil,
0.9, 1.5, 1.4, 2.0 and 2.0 each weight /
It was% by volume. From these things, sample No. 5 to No.
It was found that the 10 cyclic dipeptides have a gelling ability to organic solvents and / or oils and fats and are suitable as the gelling agent of the present invention. All the gels obtained had a uniform and smooth feel.

【0036】実施例11 cyclo(L−Leu−L−Glu(O−Et))
(試料No.1):40%、cyclo(L−Val−L
−Glu(O−Mo))(試料No.9):40%、およ
び12−ヒドロキシステアリン酸:20%からなる混合
物を80℃に加熱して均一に混ぜ、室温まで冷却した。
実施例1と同様の方法により、これを3重量/容量%お
よび8重量/容量%含む有機溶媒または油脂類を調製
し、ゲル形成能の有無を調べたところ、四塩化炭素、ベ
ンゼン、トルエン、メトキシベンゼン、クロルベンゼ
ン、トリカプリリン、トリオレインおよび大豆油につい
て、いずれも均一で滑らかな感触のゲルが得られること
を認めた。
Example 11 cyclo (L-Leu-L-Glu (O-Et))
(Sample No. 1): 40%, cyclo (L-Val-L
A mixture of -Glu (O-Mo)) (Sample No. 9): 40% and 12-hydroxystearic acid: 20% was heated to 80 ° C to uniformly mix, and cooled to room temperature.
By the same method as in Example 1, an organic solvent or fats and oils containing 3% by weight and 8% by weight of this was prepared, and the presence or absence of gel forming ability was examined. Carbon tetrachloride, benzene, toluene, It was found that methoxybenzene, chlorobenzene, tricaprylin, triolein and soybean oil all gave a gel having a uniform and smooth feel.

【0037】実施例2 cyclo(L−Gly−L−Glu(O−Et))
(試料No. 3):50%、12−ヒドロキシステアリン
酸:30%、ヒマワリワックス:10%およびミツロ
ウ:10%からなる混合物を80℃に加熱して均一に混
ぜ、室温まで冷却した。実施例1と同様の方法により、
これを1重量/容量%、7重量/容量%および10重量
/容量%含む有機溶媒または油脂類を調製し、ゲル形成
能の有無を調べたところ、クロロホルム、四塩化炭素、
ベンゼン、トルエン、メトキシベンゼン、クロルベンゼ
ン、ニトロベンゼン、トリカプリリン、トリオレインお
よび大豆油について、いずれも均一で滑らかな感触のゲ
ルが得られることを認めた。
Example 2 cyclo (L-Gly-L-Glu (O-Et))
(Sample No. 3): A mixture consisting of 50%, 12-hydroxystearic acid: 30%, sunflower wax: 10% and beeswax: 10% was heated to 80 ° C. and uniformly mixed, and cooled to room temperature. By the same method as in Example 1,
Organic solvents or fats and oils containing 1 wt / vol%, 7 wt / vol% and 10 wt / vol% were prepared, and the presence or absence of gel-forming ability was examined. Chloroform, carbon tetrachloride,
It was found that benzene, toluene, methoxybenzene, chlorobenzene, nitrobenzene, tricaprylin, triolein and soybean oil all gave a uniform and smooth-feeling gel.

【0038】比較例1 有機溶媒としてエタノール、アセトン、酢酸エチル、ク
ロロホルム、四塩化炭素、ベンゼン、トルエン、シクロ
ヘキサン、メトキシベンゼン、クロルベンゼン、ニトロ
ベンゼンを、また油脂類としてトリカプリリン、トリオ
レインおよび大豆油を選び、この各々に12−ヒドロキ
システアリン酸を1.0重量/容量%添加し、実施例1
と同様にゲル化能を調べたところ、前記有機溶媒には溶
解せず、また油脂類には溶解するものの粘性のある流動
状態を示し、いずれからも均一なゲルは得られなかっ
た。さらに前記油脂類に対して、12−ヒドロキシステ
アリン酸を2.0重量/容量%添加して同様にゲル化能
を調べたところ、ゲルは得られるが、ボソつきのあるも
ろいゲルであった。
Comparative Example 1 Ethanol, acetone, ethyl acetate, chloroform, carbon tetrachloride, benzene, toluene, cyclohexane, methoxybenzene, chlorobenzene and nitrobenzene as organic solvents, and tricaprylin, triolein and soybean oil as fats and oils. Then, 1.0% by weight / volume% of 12-hydroxystearic acid was added to each of them, and Example 1 was used.
When the gelling ability was examined in the same manner as in (1), it was insoluble in the organic solvent and soluble in fats and oils, but showed a viscous flow state, and no uniform gel was obtained. Furthermore, when 2.0% by weight / volume% of 12-hydroxystearic acid was added to the above oils and fats and the gelling ability was examined in the same manner, a gel was obtained, but it was a fragile gel with a nap.

【0039】比較例2 試料No.1〔cyclo(L−Leu−L−Glu(O
−Et))〕、試料No.8 〔cyclo(L−Gly−
L−Glu(O−Me))〕、試料No.14〔cycl
o(L−Val−L−Glu(O−Et))〕および試
料No.20〔cyclo(L−Phe−L−Glu(O
−Et))〕の各々をオクタコサノールとを用い、合成
例4に記載の方法に準じてエステル交換反応せしめ、シ
リカゲルカラムクロマトグラフィーに供して、前記環状
ジペプチドのエステル交換物を得た。これらはいずれ
も、比較例1に記載の各種有機溶媒および油脂類とはゲ
ルを形成しなかった。
Comparative Example 2 Sample No. 1 [cyclo (L-Leu-L-Glu (O
-Et))], sample no. 8 [cyclo (L-Gly-
L-Glu (O-Me))], sample no. 14 [cycl
o (L-Val-L-Glu (O-Et))] and sample no. 20 [cyclo (L-Phe-L-Glu (O
-Et))] was subjected to transesterification using octacosanol according to the method described in Synthesis Example 4 and subjected to silica gel column chromatography to obtain the transesterification product of the cyclic dipeptide. None of these formed a gel with the various organic solvents and fats and oils described in Comparative Example 1.

【0040】[0040]

【本発明の効果】本発明によれば、各種有機溶媒とりわ
けハロゲン系および芳香族系溶媒、とくにベンゼン系溶
媒、または油脂類に対してゲル化能が優れ、均一で滑ら
かなゲルを形成するゲル化剤を提供できる。
EFFECTS OF THE INVENTION According to the present invention, a gel having excellent gelling ability to various organic solvents, particularly halogen-based and aromatic-based solvents, especially benzene-based solvents, or fats and oils, and forming a uniform and smooth gel. An agent can be provided.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 グルタミン酸またはそのアルキルエステ
ルと、グリシン、アラニン、バリン、ロイシン、イソロ
イシンおよびフェニルアラニンからなる群より選ばれる
1種との下記一般式(1)で示される環状ジペプチドを
有効成分とする有機溶媒または油脂類のゲル化剤。 【化1】 〔ただし式(1)中、AはH、CH3 、(CH3 2
H、(CH3 2 CHCH2 、(C2 5 )(CH3
CHまたは 【化2】 であり、RはHまたは炭素数1〜22の直鎖状あるいは
側鎖状アルキル基である。〕
1. An organic compound comprising a cyclic dipeptide represented by the following general formula (1) as an active ingredient: glutamic acid or an alkyl ester thereof and one kind selected from the group consisting of glycine, alanine, valine, leucine, isoleucine and phenylalanine. Gelling agent for solvents or oils and fats. [Chemical 1] [However, in formula (1), A is H, CH 3 , (CH 3 ) 2 C
H, (CH 3) 2 CHCH 2, (C 2 H 5) (CH 3)
CH or And R is H or a linear or side chain alkyl group having 1 to 22 carbon atoms. ]
【請求項2】 一般式(1)において、AがH、(CH
3 2 CH、(CH32 CHCH2 または 【化3】 であり、かつRが炭素数1〜12の直鎖状あるいは側鎖
状アルキル基のいずれか1つである請求項1に記載のゲ
ル化剤。
2. In the general formula (1), A is H and (CH
3 ) 2 CH, (CH 3 ) 2 CHCH 2 or The gelling agent according to claim 1, wherein R is any one of a linear or side chain alkyl group having 1 to 12 carbon atoms.
【請求項3】 有機溶媒がハロゲン系溶媒またはベンゼ
ン系溶媒である請求項1に記載のゲル化剤。
3. The gelling agent according to claim 1, wherein the organic solvent is a halogen-based solvent or a benzene-based solvent.
JP6787594A 1994-03-10 1994-03-10 Gelling agents for organic solvents or fats and oils Expired - Fee Related JP2921731B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6787594A JP2921731B2 (en) 1994-03-10 1994-03-10 Gelling agents for organic solvents or fats and oils

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6787594A JP2921731B2 (en) 1994-03-10 1994-03-10 Gelling agents for organic solvents or fats and oils

Publications (2)

Publication Number Publication Date
JPH07247474A true JPH07247474A (en) 1995-09-26
JP2921731B2 JP2921731B2 (en) 1999-07-19

Family

ID=13357536

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6787594A Expired - Fee Related JP2921731B2 (en) 1994-03-10 1994-03-10 Gelling agents for organic solvents or fats and oils

Country Status (1)

Country Link
JP (1) JP2921731B2 (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030225103A1 (en) * 2000-08-04 2003-12-04 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
JP2004182696A (en) * 2002-12-05 2004-07-02 Shiseido Co Ltd External preparation composition
JP2004262859A (en) * 2003-03-03 2004-09-24 Shiseido Co Ltd External preparation composition
JP2004262857A (en) * 2003-03-03 2004-09-24 Shiseido Co Ltd External preparation composition
JP2004269459A (en) * 2003-03-11 2004-09-30 Nippon Unicar Co Ltd Oily cosmetic containing amino acid derivative-modified silicone
US6921747B2 (en) 2003-04-28 2005-07-26 Ajinomoto Co., Inc. Basic amino acid derivatives
US8697758B2 (en) 2008-09-24 2014-04-15 National University Corporation Shizuoka University Urea compound, self-assembly of urea compounds, organogel containing self-assembly, and method for producing organogel
US8871772B2 (en) 2008-05-27 2014-10-28 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US8962568B2 (en) 2003-05-15 2015-02-24 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US8980834B2 (en) 2011-10-10 2015-03-17 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US9034878B2 (en) 2010-09-07 2015-05-19 Ampio Pharmaceuticals, Inc. Treatment of diseases
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US9956217B2 (en) 2014-08-18 2018-05-01 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN108546250A (en) * 2018-04-04 2018-09-18 南京农业大学 Ring-Pidolidone-L-Leu and its application
US10881710B2 (en) 2011-10-28 2021-01-05 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8916568B2 (en) 2000-08-04 2014-12-23 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US10039760B2 (en) 2000-08-04 2018-08-07 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US8455517B2 (en) * 2000-08-04 2013-06-04 Dmi Acquisition Corp. Method of using diketopiperazines and composition containing them
US20030225103A1 (en) * 2000-08-04 2003-12-04 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
US8841307B2 (en) 2000-08-04 2014-09-23 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
US9561226B2 (en) 2000-08-04 2017-02-07 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
JP2004182696A (en) * 2002-12-05 2004-07-02 Shiseido Co Ltd External preparation composition
JP2004262859A (en) * 2003-03-03 2004-09-24 Shiseido Co Ltd External preparation composition
JP2004262857A (en) * 2003-03-03 2004-09-24 Shiseido Co Ltd External preparation composition
JP2004269459A (en) * 2003-03-11 2004-09-30 Nippon Unicar Co Ltd Oily cosmetic containing amino acid derivative-modified silicone
US6921747B2 (en) 2003-04-28 2005-07-26 Ajinomoto Co., Inc. Basic amino acid derivatives
US8962568B2 (en) 2003-05-15 2015-02-24 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US8969308B2 (en) 2003-05-15 2015-03-03 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US11369598B2 (en) 2003-05-15 2022-06-28 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US10828296B2 (en) 2003-05-15 2020-11-10 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US9707227B2 (en) 2003-05-15 2017-07-18 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US9730924B2 (en) 2003-05-15 2017-08-15 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US9522893B2 (en) 2008-05-27 2016-12-20 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US8871772B2 (en) 2008-05-27 2014-10-28 Ampio Pharmaceuticals, Inc. Therapeutic methods and compounds
US8697758B2 (en) 2008-09-24 2014-04-15 National University Corporation Shizuoka University Urea compound, self-assembly of urea compounds, organogel containing self-assembly, and method for producing organogel
US9034878B2 (en) 2010-09-07 2015-05-19 Ampio Pharmaceuticals, Inc. Treatment of diseases
US9623072B2 (en) 2011-10-10 2017-04-18 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US10842847B2 (en) 2011-10-10 2020-11-24 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US8980834B2 (en) 2011-10-10 2015-03-17 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US11058798B2 (en) 2011-10-10 2021-07-13 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US9925300B2 (en) 2011-10-10 2018-03-27 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US10251930B2 (en) 2011-10-10 2019-04-09 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US9060968B2 (en) 2011-10-10 2015-06-23 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
US10471178B2 (en) 2011-10-10 2019-11-12 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
US10881710B2 (en) 2011-10-28 2021-01-05 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
US11026940B2 (en) 2013-03-15 2021-06-08 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US10342793B2 (en) 2014-08-18 2019-07-09 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11090301B2 (en) 2014-08-18 2021-08-17 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US9956217B2 (en) 2014-08-18 2018-05-01 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN108546250A (en) * 2018-04-04 2018-09-18 南京农业大学 Ring-Pidolidone-L-Leu and its application
CN108546250B (en) * 2018-04-04 2021-06-11 南京农业大学 Cyclic-L-glutamic acid-L-leucine and application thereof

Also Published As

Publication number Publication date
JP2921731B2 (en) 1999-07-19

Similar Documents

Publication Publication Date Title
JP2921731B2 (en) Gelling agents for organic solvents or fats and oils
US3959248A (en) Analogs of thyrotropin-releasing hormone
EP0105777B1 (en) Lipopeptides, their manufacture and use as emulsifiers
EP0517589A2 (en) Tachykinin derivatives, their preparation and pharmaceutical compositions containing them
IE60128B1 (en) Hydroxylamine derivatives,their preparation and use as medicaments
JPS61263998A (en) Novel n-(acyldipeptidyl)-aminoglycol compound
GB2070005A (en) Processes for preparing proline derivatives and analogous compounds
JPH0543697B2 (en)
FR2460291A1 (en) NOVEL TRIPEPTIDES ACTING ON THE CENTRAL NERVOUS SYSTEM AND THEIR PREPARATION PROCESS
Ciapetti et al. Synthesis of N-Fmoc-α-amino acids carrying the four DNA nucleobases in the side chain.
JP2921732B2 (en) Gelling agents for organic solvents or fats and oils
LU83843A1 (en) NEW TRI-, TETRA- AND PENTAPEPTIDES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
Bodanszky et al. o-Nitrophenyl esters of benzyloxycarbonylamino acids and their application in the synthesis of peptide chains by the in situ technique
JP2921730B2 (en) Gelling agent for organic solvents or fats and oils
FR2511036A1 (en) PROCESS FOR PREPARING INSULIN DERIVATIVES AND PRODUCTS OBTAINED
CH635571A5 (en) TETRAPEPTIDES AND THERAPEUTIC COMPOSITION CONTAINING THEM.
BE897844A (en) BIOLOGICALLY ACTIVE TRIPEPTIDES AND TETRAPEPTIDES ALKYLAMIDES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS
SU1396970A3 (en) Method of producing derivatives of gonadoliberine
JPH0317824B2 (en)
CA2059647C (en) Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same
CH646685A5 (en) HOMOLOGATED PENTAPEPTIDES OF ENKEPHALINS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
US4257939A (en) Peptide derivative
FR2485527A1 (en) OCYTOCIN ANALOGUES AND PROCESS FOR THEIR PREPARATION
JP3061348B2 (en) Gelling agents for organic solvents and / or fats and oils
JPH01165397A (en) Enzymatic synthesis of peptide having non-proteinous primary amino acid

Legal Events

Date Code Title Description
S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees